Antibiotics needed to treat multidrug-resistant infections in neonates

Infections remain a leading cause of death in neonates. The sparse antibiotic development pipeline and challenges in conducting neonatal research have resulted in few effective antibiotics being adequately studied to treat multidrug-resistant (MDR) infections in neonates, despite the increasing glob...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Phoebe CM, Qazi, Shamim A, Agarwal, Ramesh, Velaphi, Sithembiso, Bielicki, Julia A, Nambiar, Sumathi, Giaquinto, Carlo, Bradley, John, Noel, Gary J, Ellis, Sally, O’Brien, Seamus, Balasegaram, Manica, Sharland, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2022
Materias:
Policy & Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706347/
https://www.ncbi.nlm.nih.gov/pubmed/36466207
http://dx.doi.org/10.2471/BLT.22.288623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706347/
https://www.ncbi.nlm.nih.gov/pubmed/36466207
http://dx.doi.org/10.2471/BLT.22.288623

Ejemplares similares